Self-Taught Entrepreneur Leverages AI to Build $1.8 Billion Telehealth Empire with Brother’s Support
Los Angeles, CA – In a remarkable tale of innovation and grit, Matthew Gallagher, a self-taught entrepreneur, has transformed a modest investment into a projected $1.8 billion telehealth powerhouse using artificial intelligence and strategic partnerships. Launching Medvi in September 2024, Gallagher built the company primarily from his Los Angeles home, relying on over a dozen AI tools to handle coding, content creation, and operations.
Medvi specializes in GLP-1 telehealth services, capitalizing on the surging demand for weight-loss and diabetes treatments like semaglutide. The company’s explosive growth – $401 million in sales in 2025 with 250,000 customers and a robust 16.2% net margin – has been verified by The New York Times, underscoring an AI-driven model that enables ultra-lean scaling through outsourced clinical infrastructure.
A Solo Vision with Familial Backbone
While often portrayed as a one-man operation, Gallagher’s journey involved close collaboration with his brother, who played a pivotal role in early development and decision-making. From his home setup, Gallagher deployed AI for nearly every aspect: generating software code, crafting website content, and optimizing marketing strategies. This lean approach minimized overhead, allowing rapid iteration and market entry.
“AI allowed me to punch way above my weight,” Gallagher shared in interviews. Starting with just $20,000, he bootstrapped Medvi without traditional venture capital, focusing on high-demand GLP-1 prescriptions delivered via telehealth. By outsourcing clinical operations to partners, the company maintained compliance and scalability, achieving profitability from the outset.
AI as the Ultimate Force Multiplier
Gallagher’s toolkit included large language models for code generation – reportedly writing much of the initial software – and automation for customer acquisition. This mirrors broader trends in AI entrepreneurship, where solo founders disrupt trillion-dollar industries. Medvi’s model bypasses bloated teams, using AI for everything from patient onboarding to regulatory compliance checks.
The New York Times profile highlights how Gallagher identified the GLP-1 market gap post-Ozempic boom. With shortages plaguing traditional pharmacies, Medvi’s telehealth platform offered compounded alternatives, delivered directly to patients’ doors. Projections for 2026 peg revenues at $1.8 billion, positioning it as a unicorn in the making.
Challenges and Industry Ripples
Success hasn’t come without hurdles. Regulatory scrutiny on compounded GLP-1 drugs intensified in 2025, prompting Medvi to pivot toward FDA-approved pathways. Gallagher navigated this by leveraging AI for real-time legal research and adaptation. Competitors like Hims & Hers and Ro have followed suit, but Medvi’s AI efficiency gives it an edge in margins and speed.
Experts note Gallagher’s story as a blueprint for the AI era. “This is democratizing entrepreneurship,” said one analyst. Similar feats include Higgsfield’s $200 million ARR in nine months via daily AI iterations and Surge AI’s bootstrapped billion-dollar valuation in data labeling. Yet Medvi stands out for its consumer-facing scale in healthcare.
“We iterated relentlessly, talking to users and shipping daily – AI made it possible solo.” – Matthew Gallagher
Broader Implications for AI Startups
Gallagher’s blueprint emphasizes niche focus: solve painful, underserved problems. Medvi targeted telehealth bottlenecks in weight management, an industry ripe for disruption. His brother’s involvement provided emotional and strategic support, evolving from a pure solo venture to a tight-knit duo operation.
Financials paint a vivid picture: 250,000 customers in year two, with AI optimizing retention through personalized nudges. Net margins of 16.2% dwarf industry averages, thanks to zero physical footprint and automated scaling. As Medvi eyes IPO, it signals a shift: AI isn’t just a tool; it’s the foundation of billion-dollar empires built by outsiders.
| Year | Revenue | Customers | Net Margin |
|---|---|---|---|
| 2025 | $401M | 250,000 | 16.2% |
| 2026 (Proj.) | $1.8B | N/A | N/A |
Lessons for Aspiring Founders
- Lean AI Stacks: Use LLMs for code, content, and ops to minimize team size.
- Niche Domination: Target overlooked workflows in massive markets like telehealth.
- Daily Shipping: Iterate based on user feedback, as seen in parallel AI success stories.
- Outsourcing: Partner for regulated functions like clinical care.
Gallagher’s rise challenges the VC-dominated narrative, proving self-taught founders with AI can rival incumbents. As Medvi surges toward $1.8 billion, it inspires a new generation: the era of the AI soloist is here.